Tacrolimus (FK506) for Graft-versus-host Disease after Allogeneic Blood Stem Cell Transplantation for Hematologic Malignancies

Author： Gerull S.   Luft T.   Scheuer M.   Kornacker M.   Gebest H. J.   Schőnland S.   Perz J.   Ho A. D.  

Publisher： Springer Publishing Company

ISSN： 1610-1979

Source： The Chinese-German Journal of Clinical Oncology, Vol.3, Iss.1, 2004-03, pp. : 2-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation

By Scholl Sebastian   Sayer Herbert   Mügge Lars-Olof   Kasper Christoph   Pietraszczyk Marko   Kliche Kay-Oliver   Clement Joachim   Höffken Klaus  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 12, 2004-12 ,pp. : 704-710

Springer Publishing Company

Access to resources Recommend Favorite

Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation

By Sellar Rob S   Peggs Karl S  

Future Oncology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1549-1565

Future Medicine

Access to resources Recommend Favorite

Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models

By Schwarte Sebastian   Bremer Michael   Fruehauf Joerg   Sorge Yanina   Skubich Susanne   Hoffmann Matthias W.  

International Journal of Radiation Biology, Vol. 83, Iss. 9, 2007-01 ,pp. : 625-636

Informa Healthcare

Access to resources Recommend Favorite

Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts

By Wahlin Anders  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 552-558

Humana Press, Inc

Access to resources Recommend Favorite

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen

By Saillard Colombe   Crocchiolo Roberto   Furst Sabine   El-Cheikh Jean   Castagna Luca   Signori Alessio   Oudin Claire   Faucher Catherine   Lemarie Claude   Chabannon Christian   Granata Angela   Blaise Didier  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1106-1112

Informa Healthcare

Access to resources Recommend Favorite